Patents by Inventor Alban MATHIEU

Alban MATHIEU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOGENIC COMPOUNDS FOR CANCER THERAPY
    Publication number: 20230201322
    Abstract: The invention relates to an immunogenic compound comprising an antigenic peptide having amino acid similarity with a tumor antigen, which antigenic peptide is selected in the group consisting of sequences described in the specification.
    Type: Application
    Filed: August 30, 2022
    Publication date: June 29, 2023
    Inventors: Laurent CHENE, Alban MATHIEU, Matthieu PICHAUD, Francesco STROZZI
  • IMMUNOGENIC COMPOUNDS FOR CANCER THERAPY
    Publication number: 20230080443
    Abstract: The invention relates to an immunogenic compound comprising an antigenic peptide having amino acid similarity with a tumor antigen, which antigenic peptide is selected in the group consisting of peptides having amino acid similarity with IL13RA2, the said antigenic peptide being selected in the group consisting of sequences described in the specification.
    Type: Application
    Filed: September 1, 2022
    Publication date: March 16, 2023
    Inventors: Laurent CHENE, Alban Mathieu, Matthiew Pichaud
  • Immunogenic compounds for cancer therapy
    Patent number: 11478538
    Abstract: The invention relates to an immunogenic compound comprising an antigenic peptide having amino acid similarity with a tumor antigen, which antigenic peptide is selected in the group consisting of peptides having amino acid similarity with IL13RA2, the said antigenic peptide being selected in the group consisting of sequences described in the specification.
    Type: Grant
    Filed: October 9, 2017
    Date of Patent: October 25, 2022
    Assignee: ENTEROME S.A.
    Inventors: Laurent Chene, Alban Mathieu, Matthieu Pichaud
  • Immunogenic compounds for cancer therapy
    Patent number: 11478537
    Abstract: The invention relates to an immunogenic compound comprising an antigenic peptide having amino acid similarity with a tumor antigen, which antigenic peptide is selected in the group consisting of sequences described in the specification.
    Type: Grant
    Filed: October 9, 2017
    Date of Patent: October 25, 2022
    Assignee: ENTEROME S.A.
    Inventors: Laurent Chene, Alban Mathieu, Matthieu Pichaud, Francesco Strozzi
  • Immunogenic Compounds For Cancer Therapy
    Publication number: 20200113983
    Abstract: The invention relates to an immunogenic compound comprising an antigenic peptide having amino acid similarity with a tumor antigen, which antigenic peptide is selected in the group consisting of sequences described in the specification.
    Type: Application
    Filed: October 9, 2017
    Publication date: April 16, 2020
    Inventors: Laurent CHENE, Alban MATHIEU, Matthieu PICHAUD, Francesco STROZZI
  • Immunogenic Compounds For Cancer Therapy
    Publication number: 20190388532
    Abstract: The invention relates to an immunogenic compound comprising an antigenic peptide having amino acid similarity with a tumor antigen, which antigenic peptide is selected in the group consisting of peptides having amino acid similarity with IL13RA2, the said antigenic peptide being selected in the group consisting of sequences described in the specification.
    Type: Application
    Filed: October 9, 2017
    Publication date: December 26, 2019
    Inventors: Laurent CHENE, Alban MATHIEU, Matthieu PICHAUD